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Abstract
A loss of neurons that synthesize the neuropeptide orexin produces the sleep
disorder narcolepsy with cataplexy in humans and other animals. How symptoms of this
disorder arise is not well understood, but selectively restoring orexin actions at 5-HT DR
neurons rescues key symptoms (cataplexy), suggesting normal orexin signaling is
important at these neurons. To better understand how orexin acts on these neurons, our lab
identified a set of novel orexin actions that appear mediated by unidentified cationpermeable ion channels. To narrow down the list of possible channels, we used a
bioinformatics approach to compare published gene expression profiles of 5-HT neurons
and cerebellar Purkinje neurons. These neurons, despite having different electrical
properties and different orexin responses, have cation permeable ion channels.
By using the Amigo2 database, we selected calcium channels, glutamate receptors,
histamine receptors, inositol 1,4,5-triphosphate (IP3) receptors, ryanodine receptors,
transient receptor potential (TRP) channels, potassium channels and sodium channels for
examination. We then processed single-cell RNA sequencing (scRNAseq) data available
on NCBI for 32 serotonergic neurons (SRP064626; from the Dymecki lab at Harvard) and
32 Purkinje cells (Series GSE78424). Single-cell RNA sequencing for both 5-HT neurons
and Purkinje neurons were conducted using Illumina HiSeq 2500.
After normalization of gene expression profiles of these 64 single cells and
comparisons of gene expression levels between cell clusters and cell sub-clusters, we
identified channels enriched in a subset of 5-HT neurons. Based on published channel
properties and experimental data from our lab, we isolated 39 candidate channel genes,
from which we selected the Nalcn gene for initial testing. Nalcn encodes a sodium leak and

xi

G protein-coupled receptor activated channel that regulates the resting membrane potential
and neuronal excitability. It was up-regulated in 5-HT neurons compared to Purkinje cells
(p = 1.6e-06) and it produces a membrane current with some similarities to the current
activated by orexin in these neurons.
Using a commercially available antibody, we used immunocytochemistry to
determine if the channel protein is expressed in 5-HT DR neurons. We identified an
effective concentration of the anti-Nalcn antibody to visualize the channel with light
microscopy (using VIP as a chromogen) and immunofluorescence. We first confirmed
there was Nalcn immunostaining in the DR, and then in 5-HT DR neurons using the mice
that express tdTomato fluorescence in 5-HT neurons (Sert-Cre/dTom mice). To conduct
functional studies, we intend to knockout the channel since there are no selective Nalcn
antagonists available. We utilized NalcnFL/FL mice in which the Nalcn gene was flanked by
loxP sites that enables gene knockout by Cre-recombinase expression. We first confirmed
that DR 5-HT neurons appear normal in these mice using immunofluorescence staining of
tryptophan hydroxylase (TPH), the rate-limiting enzyme for serotonin biosynthesis, and
then that Nalcn immunoreactivity was present in the DR of these mice.
Preliminary experiments to knock out Nalcn by delivering Cre-recombinase via
viral injection (AAV-Cre) into the DR of NalcnFL/FL mice are also described. Success with
using this antibody to monitor the loss of Nalcn immunostaining will confirm antibody
specificity and encourage future whole cell patch clamp experiments to functionally test if
Nalcn mediates the Orexin A action on 5-HT DR neurons. Collectively, these results will
advance our understanding of the neural mechanisms underlying cataplexy.
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A) Introduction and Background
A.1 Orexin
Orexin peptides were first identified in 1998 due to a convergence of 2 independent
research groups. Sutcliffe’s group was studying genes expressed in the hypothalamus in
relation to obesity. They isolated a series of cDNA clones that are expressed in the
hypothalamus by subtractive hybridization (de Lecea et al., 1998). Subtractive
hybridization allows comparison of genes expressed at different stages of a biological
process (Byers et al., 2000). Sutcliffe’s group discovered a secretory protein of 130 amino
acids which gave rise to 2 peptide products of similar structural characteristics. They
named these peptides hypocretin 1 and hypocretin 2, due to it being expressed in the
hypothalamus and its similarity to secretin (de Lecea et al., 1998). Around the same time,
another group, using reverse pharmacology, identified 2 peptides, they named orexin A
and orexin B, as the endogenous ligands of 2 orphan G-protein coupled receptors (GPCRs)
(Sakurai et al., 1998) they named orexin receptor 1 (OX1R) and orexin receptor 2 (OX2R).
These peptides are cleaved from prepro-orexin, which is a single precursor polypeptide
expressed by a population of neurons clustered around the perifornical lateral
hypothalamus (Sakurai et al., 1998). Later on, it was discovered that prepro-orexin and
prepro-hypocretin were identical and that orexin-A and -B corresponded to hypocretin-1
and -2, respectively.
A.2 Orexin and Narcolepsy
After the discovery of orexin, studies utilizing dog forward genetics and mouse
reverse genetics increased our understanding of hypocretin biology, which further
enhanced our knowledge of narcolepsy-cataplexy. Human narcolepsy-cataplexy is a

neurological disorder characterized by excessive daytime sleepiness, premature transition
of REM sleep, and cataplexy (Aldrich, 1998; Bassetti & Aldrich, 1996). Narcolepsy is not
a leading cause of death worldwide, but it is a disorder that is very debilitating. It affects
both sexes equally and individuals with this disorder are known to have a very poor quality
of life, sometimes even worse than patients that have epilepsy or Parkinson’s disease
(Beusterien et al., 1999; Teixeira et al., 2004). There are 2 major types of narcolepsy,
which are type 1 and type 2. Individuals with type 1 narcolepsy, or narcolepsy with
cataplexy have either low levels of the neuropeptide hypocretin or have cataplexy and
excessive daytime sleepiness (EDS). Most individuals with narcolepsy and cataplexy have
very low hypocretin-1 levels in the cerebrospinal fluid (Zawilska et al., 2012). Type 2
narcolepsy is also known as narcolepsy without cataplexy and individuals with this
experience excessive daytime sleepiness but usually do not have muscle weakness
triggered by emotion.
Cataplexy is a sudden loss of muscle tone while an individual is awake, which
leads to weakness and a loss of muscle control. It is a major symptom of narcolepsy type 1
and is often triggered by sudden, strong emotions such as laughter, fear, anger, or
excitement. Cataplexy is known to result from the loss of hypocretin containing neurons in
the lateral hypothalamus (LH) (Reading, 2019). Cataplexy symptoms may sometimes
appear years after the onset of excessive daytime sleepiness. Cataplectic attacks can range
from one attack in a lifetime to daily attacks depending on the individual. Cataplexy can
severely limit daily activities. Cataplexy is characterized by abrupt facial involvement
during laughter behavior (Pizza et al., 2018). The worse cataplectic attacks can result in a
complete body collapse which renders individuals unable to move, speak, or keep their
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eyes open. The symptoms of cataplexy differ between adults and children. A defining
aspect of cataplexy is that certain emotional stimuli usually trigger the episodes (Reading,
2019). It is known that cataplexy is caused by a severe loss of orexin neurons (Mahoney et
al., 2019), but the exact mechanism that leads to cataplexy is unknown. Although, it is
hypothesized that it might result from intrusion of REM sleep paralysis (atonia) into
wakefulness (Pintwala & Peever, 2017).
Yanagisawa’s group further investigated the role of Orexin in feeding by
constructing a null mutant mouse that didn’t produce either orexin peptide. They observed
a reduced food intake in these mice, as expected, but they also observed that these mice
would often abruptly cease movement (cataplectic attack) (Chemelli et al., 1999). They
further researched this phenomenon by creating mice lacking either of the 2 orexin
receptors. Their overall conclusion was that mice lacking orexin-2 receptor experienced
slow cessations of movement that they concluded were sleep attacks (Chemelli et al.,
1999). Around the same time, another group was successful in identifying mutations in the
OX2R gene responsible for canine narcolepsy-cataplexy by positional cloning (Lin et al.,
1999). Positional cloning is a technique that allows us to locate the position of a disease
association gene along the chromosome (Puliti et al., 2007). It was also shown later on that
orexin knock out (KO) mice were more greatly affected with cataplexy like attacks of rapid
eye movement (REM) sleep than were OX2R KO mice (Willie et al., 2003).
A.3 Localization of Orexin
Orexin neurons regulate a wide range of physiological phenomena, like
wakefulness, feeding, reward and thermogenesis (Inutsuka & Yamanaka, 2013). Orexin
containing neurons are localized in the lateral hypothalamic area (LHA), although they
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have widespread projections throughout the brain (Peyron et al., 1998). To identify the
functional neuronal network, learning about the distribution pattern of orexin receptors
could be essential. The action of orexin A and B are mediated by 2 receptors, which are
Orexin 1 (OX1R) and orexin 2 (OX2R) receptors (also known as HCRTR1 and HCRTR2).
OX1R has a much greater affinity for orexin A than it does for orexin B. Compared to that,
orexin A and orexin B bind orexin 2 receptor with similar affinities (Sakurai et al., 1998).
Both orexin 1 and orexin 2 receptor are G-protein coupled receptors, which transmit
information into cells by activating G-protein, composed of alpha, beta, and gamma
subunits (Gautam et al., 1998; Hepler & Gilman, 1992). It has been demonstrated, using in
situ hybridization, that OX1R and OX2R differ in distribution (Marcus et al., 2001). A
study was done in 2003 to examine the signal transduction pathway of orexin receptors in a
neuronal cell line. This was done by transfecting OX1R and OX2R into a nerve-like BIM
cell line. The study showed that in BIM/OX1R and BIM/OX2R cells, orexin induced an
increase in (Ekholm et al., 2007). in a dose-dependent manner and orexin A had a higher
potency on the effect of the (Ekholm et al., 2007). increase than did orexin-B in
BIM/OX1R cells (Zhu et al., 2003).
OX1R mRNA has been observed in many brain regions including the hippocampus,
paraventricular thalamic nucleus (PVN), ventromedial hypothalamic nucleus, dorsal raphe
(DR) and locus coeruleus (LC). OX2R mRNA has been observed in a similar distribution
including the cerebral cortex, hippocampus, DR, and many hypothalamic nuclei (Marcus et
al., 2001). Among these regions, the DR and LC are well known to be involved in the
maintenance of the awake state. The lateral hypothalamic (LH) orexin producing neurons
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are an important part of promoting arousal and maintain wakefulness (Alexandre et al.,
2013).
A.4 Orexin Signaling
Orexin signaling plays an important role in the maintenance of wakefulness. It has
been shown that mice lacking orexin peptides, orexin neurons, or orexin receptors show
human narcolepsy phenotypes (Hondo et al., 2010; Sakurai, 2007). Locus Coeruleus (LC)
noradrenergic neurons has been a likely candidate to prevent cataplexy due to various
studies that show cataplexy in humans and dogs is strongly suppressed by drugs that
increase noradrenergic tone and is worsened by drugs that block noradrenergic tone (Hirai
& Nishino, 2011; Nishino & Mignot, 1997). Recently, It has also been found that
cataplexy like episodes can be inhibited by targeted restoration of orexin receptor
expression in the DR and in the LC of mice lacking orexin receptors (Hasegawa et al.,
2014). This suggests that the activation of LC noradrenergic neurons is not sufficient to
suppress cataplexy in narcoleptic mice (Hasegawa et al., 2014).
Orexin peptides are synthesized by a small group of neurons in the hypothalamus
(de Lecea et al., 1998) and are widely distributed in the central nervous system (CNS)
(Peyron et al., 1998). The CNS is one of the most important orexin target tissue and the
CNS neurons are the most investigated cells for orexin responses. Orexins are shown to
produce a slow and long-lasting depolarization that can be large enough to initiate firing of
a neuron. Orexin receptors couple to effectors that produce depolarization, whose
molecular identity is generally not known, and are known as excitatory neuropeptides
(Leonard & Kukkonen, 2013). The depolarization is usually attributed to the closure of K+
channels active at rest, activation of an electrogenic sodium-calcium exchanger (NCX),
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and the activation of non-selective cation channels (NSCCs) (Eriksson et al., 2001;
Horvath et al., 1999; Hwang et al., 2001).
A.5 The Dorsal Raphe
A chemical present in abundance in the dorsal raphe is serotonin (5-HT). 5-HT is
an essential chemical that is found in all organs in mammals, such as brain, lungs, liver,
kidney and skin. The distribution of 5-HT is widespread in the brain and it regulate the
activity of nearly all brain regions. This is why 5-HT has been implicated in a variety of
brain functions, some of which are the sleep-wake cycle, hormonal regulation, and appetite
(Nakamura, 2013). There has been much controversy on the role of 5-HT in sleep. The first
hypothesized sleep-promoting substance of modern neuroscience was 5-HT. It was
reported in 1955 that reserpine could decrease cerebral 5-HT and induce sedation or a
“sleep like state” (Brodie et al., 1955). This was the first time that sleep and serotonin were
mentioned together in a paper. Then in 1965, it was discovered that the administration of
reserpine could trigger the continuous appearance of Ponto geniculo occipital (PGO)
activity, even during waking (Jouvet-Mounier et al., 1965). PGO waves are biphasic field
potentials that are identified in a wide range of mammals, which are related to sleep and
are known to be identified in waking perception and eye movement. It is also known that
PGO waves are early predictors for the onset of REM sleep (Gott et al., 2017). It has also
been shown that the action of reserpine was blocked by the monoamine oxidase inhibitors,
pheniprazine, harmaline and clorgyline (Gershon & Brooks, 1976).
In the central nervous system (CNS), the raphe is a diffuse network of brainstem
nuclei, that synthesizes 5-HT and send projections to almost every region of the brain
(Azmitia & Segal, 1978). Studies have shown that ablation of the raphe in cats reduced
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serotonin levels and sleep, in proportion to the size of the lesion (Jouvet, 1968). It has also
been shown that intraperitoneal injections of para-chlorophenyl alanine (pCPA) also
reduced sleep (Koella et al., 1968). These studies gave rise to the theory of sleep, in which
serotonin plays an important sleep-promoting role. Additional finding show that
serotonergic raphe neurons are active during wakefulness, less active during non-rapid eye
movement (NREM) sleep, and mostly silent during rapid eye movement (REM) sleep
further support a wake-promoting role for serotonin and the raphe (McGinty & Harper,
1976).
Serotonergic neurons in the dorsal raphe nucleus (DRN) play important roles in
many physiological processes such as sleep/arousal, mood control, and regulation of food
intake (Leibowitz & Alexander, 1998). Orexin A is known to strongly excite dorsal raphe
(DR) serotonergic neurons, which is shown by studies done in vitro (Brown et al., 2001). It
has also been shown that the lateral hypothalamus-raphe connection mediated by orexin A
might contribute to a negative feedback loop regulating food intake. The release of orexin
A in various hypothalamic and brainstem nuclei elicit feeding but also excite serotonin
neurons, which results in an enhanced release of serotonin in the ventromedial
hypothalamus (Leibowitz & Alexander, 1998; Sakurai et al., 1998). Along with the
regulation of food intake, these results by brown show an importance in the context of
narcolepsy. In narcolepsy, REM sleep episodes intrude into normal waking and serotonin
has a suppressive effect on REM sleep generation (Jacobs & Fornal, 1999). Orexin
signaling in DRN 5-HT neurons appears critical for the suppression of cataplexy.
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A.6 Orexin and calcium channels
A major response upon the activation of orexin receptor is Ca2+ influx, which leads
to the amplification of other responses mediated by orexin receptors (Sakurai et al., 1998).
PLC activation and the binding of OX1R and OX2R are strongly dependent on the
extracellular Ca2+ concentration. It is shown in a study that when Ca2+ entry is reduced by
depolarizing the cells or by inhibiting the receptor-operated Ca2+ channels, orexin A
stimulated Phospholipase C activity was much more strongly inhibited than orexin A
binding (Putula et al., 2014). This suggests to us that calcium plays a double role in orexin
signaling by amplifying orexin signals via Ca2+ influx and being a prerequisite for both
ligand-receptor interaction (Putula et al., 2014). Orexin is known to increase the
intracellular calcium concentration in expression systems. It is known that both OX1 and
OX2 receptors release Ca2+ from intracellular stores and that a primary Ca2+ influx is
evoked at lower orexin concentrations (Kukkonen & Leonard, 2013). Orexin receptors
throughout the CNS are known to drive membrane depolarization and increase the
intracellular Ca2+ levels (Leonard & Kukkonen, 2013). Orexin is known to modulate
calcium in the DR (Kukkonen & Leonard, 2013; Liu et al., 2002). The application of
orexin is also known to produce membrane depolarization and action potential in DR
neurons (Brown et al., 2002; Burlet et al., 2002). Orexin is also known to elicit Ca2+
transients in the soma and dendrites of neurons in the dorsal raphe (Kohlmeier et al., 2004;
Kohlmeier et al., 2008). It is also shown that Orexin A (OXA) enhances a late
afterhyperpolarization (AHP) in serotonergic neurons which is Ca2+ dependent (Ishibashi
et al., 2016). Recently, it has been seen that extracellular calcium also block the orexin
mediated inward current (Leonard lab Figure 6, unpublished)
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A.7 Orexin and glutamate receptors
Orexin A administration is known to modulate glutamatergic thalamocortical
synapses and facilitates attention (Lambe et al., 2005). Also, in the hippocampus, orexin A
is known to modulate synaptic plasticity through coordinated modulation of cholinergic,
GABAergic, glutamatergic, and noradrenergic signaling (Selbach et al., 2004). It is also
shown in a study that the administration of Orexin A, rapidly and significantly increases
ACh and glutamate within the PFC (Calva et al., 2018). Orexin A is also known to
colocalize with glutamate (Torrealba et al., 2003). Glutamate receptor modulation by
orexin signaling is also shown in the ventral tegmental area (VTA), where orexin is shown
to increase N-methyl-D-aspartate receptors (NMDARs), which leads to increased
AMPAR/NMDAR ratio (Borgland et al., 2006). AMPA and NMDA are shown to increase
the 5-HT neuronal firing in the DRN (Gartside et al., 2007). Studies have also shown that
agonists of ionotropic glutamate receptors have activated orexin neurons and that
glutamate antagonists have reduced their activity (Li et al., 2002; Yamanaka et al., 2003).
This suggests that orexin neurons are tonically activated by glutamate.
A.8 Orexin and histamine effectors
The enhancement of orexinergic system through the Orexin 2 receptors is known to
excite the histaminergic system (Eriksson et al., 2001). Histaminergic neurons are localized
to the tuberomammillary nucleus (TMN) of the posterior hypothalamus and send extensive
projections throughout the CNS (Wada et al., 1991). The TMN also predominantly
expresses orexin 2 receptors (Eriksson et al., 2001), which has an affinity to bind orexin A
(Sakurai et al., 1998). Increases of histamine concentration in the hypothalamus has been
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shown to help excessive daytime sleepiness in narcolepsy and also help cataplexy control
(Reading, 2019).
A.9 Orexin and ryanodine receptors
Functional coupling between IP3R and RyR could be a critical component of
intracellular Ca2+ signaling in many excitable cells (Tjondrokoesoemo et al., 2013). The
activation of IP3 receptor in response to cAMP signaling is a PKA-dependent mechanism
and the activation of ryanodine receptors is an EPAC dependent mechanism (Kang et al.,
2003; Tsuboi et al., 2003). It is shown in a study that Orexin A potentiated glucosestimulated insulin secretion, which increases [Ca2+]i levels, through adenylate cyclase and
ryanodine receptor activation (Park et al., 2015). Activation of ryanodine receptors and
Ca2+ release from intracellular stores is shown to enhance the SK component of the oeAHP
(Ishibashi et al., 2016). It is also shown in this study that the activation of IP3 receptors
might not be necessary or sufficient.
A.10 Orexin and TRP channels
The transient receptor potential (TRP) protein superfamily is a diverse group of ion
channels that consist of 28 cation permeable channels that are grouped into 6 subfamilies
(Samanta et al., 2018). These channels show great diversity in activation, inhibition and
selectivity of ion conductance. TRP cation channels are known to mediate the flux of Na+
and Ca2+ across the plasma membrane and into the cytoplasm (Song & Yuan, 2010). It has
been shown that TRP channels are activated by G-protein coupled receptors (GPCRs) or
receptor tyrosine kinases (Plant & Schaefer, 2003; Trebak et al., 2007). The TRP channels
are Na2+ permeable channels that are mediated by Orexin. Studies have shown that
Transient receptor potential channel 3 (TRPC3) is activated when orexin A act on Orexin 1
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receptor, thus triggering Ca2+ responses (Peltonen et al., 2009). This suggest that a change
in calcium levels is not necessarily mediated through G-protein Coupled receptors
(GPCRs) and that orexin receptors activate a novel mechanism of [Ca2+]i elevation through
nonselective cation channels (NSCCs) (Wang et al., 2018). Orexin signaling is also known
to activate the mTORC1 pathway, which is triggered by the lysosomal v-ATPase pathway,
which is dependent on transient cytoplasmic calcium (Wang et al., 2014).
A.11 Orexin and potassium channels
Orexin neurons are inhibited by an increase in temperature, which is mediated by
ATP-sensitive potassium (KATP) channels (Parsons et al., 2012). Two-pore domain
potassium channels become activated with increasing temperatures in cerebellar granule
neurons and dorsal root ganglion neurons (Kang et al., 2005). ATP-sensitive K+ channels
are also known to mediate lactate effect on orexin neurons (Parsons & Hirasawa, 2010)
and Extracellular lactate concentration is known to be a reliable sleep/wake biomarker
(Naylor et al., 2012). Orexin neurons are also known to be inhibited by glucose. This
inhibited is mediated by tandem-pore K+ (K2p) channels (Burdakov et al., 2006).
A.12 Orexin actions on the DR
Orexin has been shown to have more complex effects in the DR, but like the
remaining CNS, the molecular identity of the effectors is not known. In addition to
producing membrane depolarization, orexin A (OXA) enhances a late
afterhyperpolarization (AHP) in serotonergic neurons and this orexin enhanced AHP
(oeAHP) is Ca2+ dependent.(Ishibashi et al., 2016). Functionally, the AHP is a feedback
mechanism that shapes the firing frequency and firing pattern in many types of neurons
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(Duménieu et al., 2015). The Modulation of the AHP represents an important mechanism
by which excitability of a neuron can be regulated (Burrell & Crisp, 2008).
The orexin effect on the DR slow AHP is illustrated in Figure 1. Application of
orexin produces an inward current (downward shift in the trace) that depolarizes 5-HT DR
(Figure 1A). The vertical transients indicate brief test pulses to activate the AHP. These
current quickly settle to baseline before orexin is applied but then get larger and slowly
settle to baseline after orexin is applied (dotted box) indicating the AHP current has been
enhanced by orexin (IoeAHP). Looking on a faster time scale (Figure 1B), there are 2
parts to the IoeAHP, one of which is a slow decaying part that was not blocked by apamin
and the second is a faster decaying part that was blocked by apamin. This indicates that the
fast part is mediated by SK-type Ca2+ -activated K+ channels. The apamin insensitive part
(Iai-oeAHP) was consistently about half the size of the inward current which suggest that
these currents may be linked (Ishibashi et al., 2016; Ishibashi and Leonard, unpublished
observations). Several lines of evidence suggest that the slower decaying, apamin
insensitive current results from Ca2+ influx that transiently closes the very cation
channel(s) activated by orexin. One way this could happen in 5-HT DR neurons is
illustrated in the schematic below (Figure 1C). In this scheme, either OX1R or OX2R
activation is sufficient to induce the inward current and the oeAHP by activation of PLC.
This activates one or more types of non-selective cation channels (NSCCs) through
unknown signals, but without involvement of the SER Ca2+ -stores, RyRs or IP3Rs
(Ishibashi et al., 2016). A transient influx of Ca2+ through voltage-gated Ca2+ channels is
sufficient to transiently reduce the inward current (NSCC) by about half after binding to an
unidentified neuronal Ca2+ sensor protein (NCS), thereby producing the novel ai-oeAHP.
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In this scheme the NSCC plays a pivotal role in both orexin excitation and in the oeAHP.
Since the molecular identity of the NSCC is not known, it will be of significant interest to
determine the NSCCs expressed in 5-HT DR neurons.
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Figure 1 | OXA produces an inward current that depolarizes serotonergic DR neurons and also
enhances a novel late AHP which is likely mediated by the closure of the cation channels carrying the
inward current.
A) OXA application induces a large noisy inward current. The AHP was periodically tested by delivering 5
brief (10 ms) depolarizations to +10 mv at 20 Hz (vertical transients). Prior to OXA, the membrane current
quickly settled to baseline. After OXA, a slow outward current, termed the IoeAHP, followed these pulses
(blue box). B) The IoeAHP (top trace) was composed of two components: a slower decaying part that was
not blocked by apamin (Apamin; middle trace) which is termed the apamin-insensitive oeAHP (Iai-oeAHP)
and a faster decaying part that was blocked by apamin (bottom trace) indicating it was mediated by SK-type
Ca2+ -activated K+ channels. Modified from Ishibashi et al., 2016. C) A schematic summarizing our working
hypothesis for the ai-oeAHP. This is based on the data above and other data obtained in the Leonard Lab
(Ishibashi and Leonard, unpublished observations).

As noted in Ishibashi et al (2016), the functional impact of the oeAHP is to alter the
firing properties of 5-HT DR neurons so as to reduce tonic firing without attenuating
transient firing during active waking, when orexin is released. The loss of orexin in
narcolepsy would degrade these firing changes and may contribute to the narcolepsy
phenotype.
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With these data in mind, the work described here will use a combination of
bioinformatics and knockout approaches to identify some potential candidate effectors
mediating the action of orexin in serotonergic DR neurons.
A.13 Single-cell RNA sequencing
Single-cell RNA sequencing (scRNA-seq) is a powerful tool for transcriptome
analysis that can measure the distribution of expression levels for each gene across a
population of cells (Parsons et al., 2012). scRNA-seq allows comparison of individual cell
transcriptome, which is why it has been used to assess transcriptional similarities and
differences within a population of cells (Haque et al., 2017). The assessment of
transcriptional differences between individual cells can be used to identify rare cell
populations (Parsons & Hirasawa, 2010), like malignant tumor cells in a tumor mass
(Naylor et al., 2012). scRNA-seq is also being used to trace developmental relationships
between heterogenous, yet related, cellular states in scenarios such as lung epithelial
differentiation (Treutlein et al., 2014). In addition to this, scRNA-seq can also provide
important information about essential characteristics of gene expression, such as
monoallelic gene expression (Deng et al., 2014).
scRNA-seq can be very helpful in finding answers to research questions, but it’s
important to recognize that the answers can vary depending on the protocol used. RNA-seq
is a great technique for the quantitative analysis of messenger RNA molecules in a
biological sample (Haque et al., 2017). This is a useful approach for studying cellular
responses. Before any analysis can be done, it is important to filter and normalize the data.
Data normalization is important for RNA-seq because it addresses limitations presented by
low amounts of material and various forms of bias in the sequencing process (Lytal et al.,
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2020). There are several methods available for data normalization, some of which rely on
spike-in genes, referring to the genes whose expression is higher in a certain subgroup
(Vallejos et al., 2015).
A.13.1 Clustering analysis
Clustering analysis is used to generate cell type-specific clusters by using cell type
marker genes. The different types of clustering are unsupervised clustering, k-means
clustering, hierarchical clustering, and graph-based clustering. Unsupervised clustering has
been studied in machine learning and has many different applications. This type of
clustering does not depend on predefined classes and training examples while classifying
the data (Tasoulis et al., 2006). In k-means clustering, the cluster center is predetermined
and each cell is assigned to the nearest cluster (James et al., 2013). Hierarchical clustering
is the most popular method for gene expression analysis. In this method, genes with similar
expression patterns are grouped together and are connected by a series of branches.
Hierarchical clustering can also be used to group together experiments similar expression
profiles (Pagnuco et al., 2017).
A.13.2 Heat map analysis
Heat map is a great tool for visualizing complex statistical data, using colors to
represent values. It shows magnitude of expression as color in two dimensions. In a color
intensity ranging from blue (no expression) to orange (highest expression), it shows how
much or how little a specific gene is expressed in each cell. They are useful for visualizing
the expression of genes across individual samples and are commonly used to visualize
scRNA-seq results (Batut et al., 2018). To generate a heatmap, the gene counts need to be
normalized for differences in sequencing depth and composition bias between the samples
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(Batut et al., 2018). Sequencing depth refers to the average number of nucleotides
contributing to a portion of an assembly, referring to how many times each base has been
sequenced. Normalizing for composition bias takes into account certain genes that are very
highly expressed in a group.
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B) Hypothesis and Specific Aims
B.1 Hypothesis
The loss of orexin can result in the sleep disorder narcolepsy with cataplexy in
humans and other animals. How symptoms of this disorder arise is not well understood,
but selectively restoring orexin actions at 5-HT DR neurons rescues key symptoms
(cataplexy), suggesting normal orexin signaling is important at these neurons (Hasegawa et
al., 2014). To better understand how orexin acts on these neurons, our lab identified a set
of novel orexin actions that appear mediated by unidentified cation-permeable ion
channels. To narrow down the list of possible channels, we used a bioinformatics
approach to compare published gene expression profiles of 5-HT neurons and cerebellar
Purkinje neurons. These neurons, despite having different electrical properties and
different orexin responses, have cation permeable ion channels.
B.2 Specific Aims
B.2.1 Aim 1: Analysis of published gene profiles of serotonergic neurons and
cerebellar Purkinje neurons.
Our lab previously identified a set of novel orexin actions that appear mediated by
unidentified cation-permeable ion channels. After arriving with several groups of channels,
using the Amigo2 database, we compared the gene expression profiles of the individual
genes. For this we choose to compare serotonergic neurons with Purkinje cells, due to the
difference in electrophysiology of both types of neurons. We processed and analyzed
(using R) the single-cell RNA sequencing (scRNAseq) data available on NCBI for 32
serotonergic neurons (SRP064626; from the Dymecki lab at Harvard) and 32 Purkinje cells
(Series GSE78424). Then the gene counts were separated depending on which group of
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genes were needed for analysis. The 32 serotonergic cells were compared with the 32
Purkinje cells using R and an automated single cell analysis pipeline (ASAP).
B.2.2 Aim 2: Testing a Candidate Ion channel
Based on the published channel properties, experimental data from our lab, and the
scRNA-seq data analyzed, we identified 7 candidate channel genes, from which we
selected the Nalcn gene for initial testing. Nalcn encodes a sodium leak and G proteincoupled receptor activated channel that regulates the resting membrane potential and
neuronal excitability. It was up-regulated in 5-HT neurons compared to Purkinje cells (p =
1.6e-06) and it produces a membrane current with some similarities to the current activated
by orexin in these neurons. It was first confirmed using immunostaining that Nalcn was
present in the dorsal raphe. Then it was tested whether Nalcn was present in 5-HT DR
neurons. After confirmation, the next step was to conduct functional studies, for which we
intended to knockout the channel by injecting a GFP Cre virus into the DR of NalcnFL/FL
mice.
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C) Materials and Methods
Aim 1: Analysis of published gene profiles of serotonergic neurons and cerebellar
Purkinje neurons
C.1 Processing raw scRNA-seq data
C.1.1 Obtaining scRNA-seq data
The scRNA-seq data used throughout this work was obtained from the Gene
Expression Omnibus (GEO) database. The serotonergic neuron samples used were from
the study “Multi-scale molecular deconstruction of the serotonin neuron system”
(SRP064626) done by the Dymecki lab at Harvard Medical School (Okaty et al., 2015).
Cells were obtained from manually sorted GFP-expressing neurons of triple transgenic
En1::Cre, Pet1::Flpe, RC::PFtox male mice, from Dorsal Raphe. Then total RNA was
recovered using picopure RNA isolation. Afterwards, the Nugen Ovation RNASeq system
v2 was used for RT and linear amplification, which was followed by Covaris sonication
and Nugen Ultralow for library preparation. Fifteen of the single cells obtained were from
the dorsal raphe and 15 were from the median raphe. The cerebellar Purkinje neurons used
were from mouse ENCODE project (Series GSE78424). The 32 samples were obtained
from scRNA-seq of 20 excised and homogenized Purkinje neurons from male wild type
C57Bl6 mice. The instrument used for the scRNA-seq of both serotonergic neurons and
Purkinje neurons was Illumina HiSeq 2500. The SRR number (raw files) for all 64 cells
were recorded in notebook.
C.1.2 Loading and saving raw scRNA-seq data
Each individual cell was processed separately. The raw file for each of the 64 cells
was loaded onto a computer running Ubuntu Linux (version 16.04), using SRAtoolkit
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(command: prefetch SRR##; version 8). Then the data was converted to fastq files
(command: fastq-dump). Both SRA and fastq files were saved into a specified folder. This
was repeated for all 64 cells and the fastq file for each cell was saved into a separate folder.
C.1.3 Checking quality of reads
After obtaining scRNA-seq data, the quality of reads was checked using FastQC
(version 0.11.9), which is a quality control tool for sequencing data. It takes input data and
returns a report on read quality. Both reports of forward and reverse reads were checked
for any flaws. Then the reads were trimmed using TRIM GALORE (version 0.5.0) to
remove any adapters and/or low-quality sequences. After trimming, another FastQC report
was generated to check the quality of the trimmed results. This new FastQC report showed
that the reads pass the ‘adaptor content’ plot. Fastq is the raw reads of scRNA-seq data.
C.1.4 Alignment of reads
After trimming the reads, the next step is to map them to a reference genome. This
process is called alignment. The reference genome for Mus musculus was downloaded
from Ensembl in GTF format (Ensembl release 102). Alignment is usually needed to
quantify gene expression or find genes which are differentially expressed between samples.
Kallisto (version 0.46.1) was used for pseudo-alignment of reads to the reference
transcriptome (version GRCm38.91). Kallisto allows for pseudo-aligning reads from
scRNA-seq experiments. Kallisto pseudo-aligns reads to a reference transcriptome rather
than a reference genome and maps reads to splice isoforms rather than genes. The four
output files from the kallisto alignment were saved to a specified folder.
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C.1.5 Construction of expression matrix
In an expression matrix, each column represents a cell, and each row of the
expression matrix represents a gene. Each entry represents the expression level of a
particular gene in a given cell, by which the expression is measured.
C.2 Analysis of single cell RNA-seq data
C.2.1 Categories of channels
After forming the gene counts with expression levels, they were saved in a
worksheet in csv format. Different files were constructed for each category of channels that
needed to be analyzed. The categories of channels and receptors selected were calcium,
glutamate, histamine, ryanodine, TRP, and potassium. These list of genes from each
category was constructed using the Amigo2 Gene Ontology (GO) database. Amigo2 was
used to filter out and identify genes with certain parameters. The parameters entered to
conduct the list of channels were ion channels, neurons, GPCR, calcium, glutamate,
histamine, ryanodine, TRP, potassium, and non-voltage genes. This produced a list of a
few hundred genes, which were separated into different classes of genes and analyzed. R
(version 3.6.2) was initially used to visualize the gene expression of some channels to
make sure the reads were properly processed. Further analysis of the groups of channel
genes was done using ASAP.
C.2.2 Filtering and Normalization
Before any analysis, the data were filtered and normalized. This was done
separately for each group of channel genes using ASAP. The results were filtered using
Transcripts per million reads (TPM).
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Then the data was normalized to counteract any technical noise, due to imprecise
measurements (Lytal et al., 2020) or biological variation attributed to the natural
differences among the cells under the same biological condition (Kim et al., 2015). The
goal of normalization is for the differences in the normalized read counts to represent
differences in the true expression (Evans et al., 2018). Each class of genes that were
analyzed were filtered and normalized separately.
C.2.3 Cell clusters
After normalization, a t-distributed stochastic neighbor embedding (tSNE) plot was
generated using k-means clustering with a perplexity of 21 and a theta of 0.5. tSNE is a
dimension reducing method for visualizing high dimensional data. In the scRNA-seq data,
it shows the gene expression measurements per cell in two dimensions. The plot is
constructed in a way that when two cells are close in the lower dimension space, they are
likely close in the higher dimension space as well. In the plot, only the relative distance
between each cell (point) matter (Hollt et al., 2018). tSNE is primarily a visualization
technique and that shows you how the data is arranged in a high dimensional space. Here,
the tSNE plot showed two cell clusters which distinguished between the serotonergic
neurons and the Purkinje neurons. In a tSNE plot, you set a low perplexity when you want
a more local scale analysis and are only concerned about the few closest points. In our
analysis, we used a high perplexity 21, which gives us a more overall picture (Hollt et al.,
2018). So, with a high perplexity, it focuses on the overall group of cells, instead of each
individual cell and its closest counterpart. To get the overall differentiation between
serotonergic neurons and Purkinje cells, any perplexity value between 5 and 50 should
work fine. For the tSNE plot, a lower theta value (between 0 and 1) was chosen because a
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low value leads to a slower but finer approximation of the data. With a higher theta value,
you would get a faster but coarser approximation (Hollt et al., 2018).
C.2.4 Heat maps
Heat maps for each category were generated using the normalized data of both
serotonergic neurons and Purkinje neurons. Ward D2 clustering method was used to
generate the heat maps to show the hierarchical clustering. The distance metric used was
Euclidean.
C.2.5 Differential Expression (DE)
DE was done on each group of channel genes using Limma on ASAP. This was
done on the filtered and normalized data. The false discovery rate (FDR) was set to less
than or equal to 0.05. The fold change was set to more than or equal to 2. FDR is a method
to determine the rate of type 1 errors in null hypothesis testing when doing multiple
comparisons. Fold change is a value that shows how much a quantity changes between an
original and a subsequent measurement.
Aim 2: Testing a Candidate Ion channel
C.3 Mice
Wildtype C57Blk6, Sert-Cre::dTom, and NalcnFL/FL mice were utilized for all the
experiments in this study. All strains were already available at NYMC comparative
medicine. Mice were kept in a pathogen-free environment and all experiments were
conducted on male mice who were at least 14 weeks of age. All animal procedures were
conducted in accordance with the institutional animal care and use committee (IACUC)
guidelines approved by New York Medical College.
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C.4 Cre Injection Surgery
NalcnFL/FL mice were anesthetized using ketamine/xylazine cocktail and 300 ul of
Cre virus was injected into the DR region (Figure 2). The Surgery was done using a
stereotaxic (Figure 3) and the virus was injected nanoject 2. The DR location was mapped
using the Angle2 z axis software and measuring Bregma and lambda. The AAV9 cre virus
injected was pENN.AAV.hSyn.HI.eGFP-Cre.WPRE.SV40 (add gene 105540-AAV9; 1
x10 13 vg/ml). The pipettes used for the injection were 3.5-inch Drummond pipettes and
were pulled on a Sutter P-95 horizontal pipette puller and broken back to tip diameters of
20-25um.

Bregma
Lambda
Dorsal Raphe

Figure 2 | DR region of NalcnFL/FL mouse where Cre virus was injected.
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Stereotaxic

Pipette holder

Ear bars

Figure 3 | Stereotaxic setup with NalcnFL/FL mouse in ear bars
Mouse is placed in a heat pad and held onto stereotaxic by the ear bars with a Pipette holder pointed and the
dorsal raphe region at 0 degrees, which contains a 25um thick pipette with GFP Cre virus inserted into it.

C.5 Perfusions
Mice were deeply anesthetized using ketamine/xylazine cocktail and then perfused
with 4% paraformaldehyde (PFA). Brains were then collected and placed in 4% PFA for
24 hours and then switched to 30% sucrose to cryopreserve the tissue.
C.6 Sectioning Brains
Brains were flash frozen using methyl butane and then frozen in a cube of OCT.
Brain sections (40um) of the DR were made using a Leica cryostat. Each section was
collected separately and placed in a 24-well plate with 0.01M PBS solution.
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C.7 VIP Immunohistochemistry
On the first day, the desired sections were added to a 24-well plate and washed
with 0.01M PBS for 15 minutes. Then the sections were incubated for 30 minutes in 500ul
of 1% H202 in 0.01M PBS with continuous agitation. H202 was then removed, and the
sections were washed with PBS for 15 minutes. Then the sections were blocked for nonspecific binding with 500ul of 1% BSA/ 0.05% sodium azide/ 0.01M PBS solution for 45
mins with continuous agitation. At the end of day 1, 500ul of [1:100] Anti-Nalcn
extracellular antibody (Lot#: ASC022AN0150; Cat #: ASC-022; Alomone labs) was added
to the sections and they were left at 4 degrees Celsius for 2-night incubation with
continuous agitation.
After 2-day incubation, the primary antibody was removed from the sections and
they were washed with PBS for 100 minutes. Then the secondary antibody, 500ul of
[1:200] biotinylated anti rabbit IgG (Lot#: ZD1113), was added to the sections and
incubated for 60 minutes with continuous agitation. ABC solution was them prepared with
5ml PBS, 2 drops of Avidin DH, and 2 drops of biotinylated horse radish. Then, 500ul of
the ABC solution was incubated for 30 mins and added to the sections, after they were
washed with PBS for 15 minutes. The sections were incubated with ABC solution for 30
mins and then washed with PBS for 15 mins. 500ul of VIP solution was then prepared and
added to the sections, individually, for around 3 mins until reaction. Then the sections were
immediately washed with PBS to stop the reaction. The sections were then mounted on
slides and dipped in newly made 80% EtOH for 1 minutes, 90% EtOH for 1 minutes, and
100% EtOH for 1 minute. Then the sections were dipped in xylene for 2 minutes and
removed and to coverslip using permount.
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C.8 Immunofluorescence
Sections with cre expression were added to 24-well plate and washed with 0.01M
PBS for 15 mins. Sections with cre expression were covered with foil during all steps. The
sections were then blocked for non-specific binding in 500ul of 1%BSA/ 0.05%
azide/0.01M PBS solution for 60 minutes. Then 500ul of [1:100] primary Nalcn antibody
(Lot#: ASC022AN0150) was added to the sections and left at 4 degrees Celsius for 2-day
incubation with continuous agitation and foil covering.
After 2-day incubation, the sections were washed for 100 minutes with continuous
agitation. Then the sections were incubated in 500ul of secondary antibody, Alexa fluor
594 (Lot#: 1987293), for 45 minutes. the sections were then mounted, dried and cover
slipped with 25ul of Vectashield.
C.9 Microscopy
All images of brain sections were taken using a Keyence BZ-X800 fluorescent
microscope under high resolution with 4X, 20X and 60X objectives.
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D) Results
Aim 1: Analysis of published gene profiles of serotonergic neurons and cerebellar
Purkinje neurons
D.1 Analysis of gene profiles
scRNA-Seq data for 32 serotonergic neurons and 32 cerebellar Purkinje neurons
were processed for comparison of gene expression levels between cell clusters and cell
sub-clusters. Because of the difference in electrophysiology between serotonergic neurons
and Purkinje cells, we expect the channel and receptor profiles to be strongly different
between these cell types. These differences in conjunction with the known actions of
orexin on DR 5-HT neurons may help identify candidate ion channels modulated by orexin
A. To visualize and confirm the differences between the serotonergic neurons and Purkinje
neurons, a tSNE plot was generated from the analysis of 64 cells and 30,244 genes (Figure
4). The two clusters of cells could clearly be visualized, differentiating between
serotonergic neurons and Purkinje neurons. There was one DR cell among the Purkinje
cells, which could be due to an error in the scRNA-seq or the normalization, but it cannot
be said with certainty with this information.
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Figure 4 | Cell cluster formation.
tSNE plot generated from the analysis of 62 cells and 30,244 genes, using k-means clustering on normalized
data with a perplexity of 21 and theta of 0.5.

Afterwards several functional gene groups were formed for the analysis of their
relative gene expression profiles. These different groups of channel and receptor genes
were constructed using the Amigo2 GO database with specific filters for novel orexin
actions. For the calcium channels, the filters used were ion channels, neurons, GPCR and
calcium. This gave us a list of 23 genes which were examined using scRNA-seq expression
data.
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The data was then filtered with TPM and normalized with log 2 expression for each
group of genes. A heat map was generated to visualize the overall gene expression of both
serotonergic and Purkinje neurons. Then, statistical analysis was done to determine the
statistical significance of certain upregulated and downregulated genes.
D.2 Analysis of calcium channel genes
A list of calcium channel gene subunits was constructed using Amigo2 and the
corresponding expression profiles were analyzed and compared between serotonergic
neurons and Purkinje neurons. The difference between the dorsal and median raphe can be
seen by the hierarchical clustering in the top of the heat map (Figure 5). The heat map
shows the absolute levels of expression of the Purkinje neurons and serotonergic neurons.
The heat map (Figure 5) also shows that eight genes have similar expression between the
serotonergic and Purkinje neurons. It shows that at least 14 genes have higher gene
expression in serotonergic neurons, whose statistical significance (p-value < 0.05) is
confirmed (Table 1). The green labels indicate genes upregulated in serotonergic neurons
and the red labels indicate downregulated.
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Figure 5 | Heat map of calcium channel genes
Showing gene expression of individual cells of both serotonergic neurons (right) and Purkinje neurons (left)
with hierarchical clustering of the neurons (top) and channels genes (left).
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Gene Name

log (Fold change)

p-value

FDR

Cacna2d1
9.02
7.19e-33
8.26e-32
Cacna1b
8.66
6.41e-33
8.26e-32
Cacna1e
6.96
9.99e-21
7.65e-20
Cacng3
5.92
3.69e-16
2.12e-15
Cacna1c
4.99
3.56e-15
1.63e-14
Cacnb1
4.82
7.10e-15
2.72e-14
Cacna1h
3.90
1.18e-08
3.38e-08
Cacng7
2.39
5.87e-07
1.35e-06
Cacnb2
2.22
1.41e-06
2.94e-06
Cacng4
2.01
0.00041
0.00067
Cacna1a
1.91
8.52e-06
1.63e-05
Cacna2d4
1.52
0.00040
0.00067
Cacna1i
1.45
0.022
0.031
Cacna2d2
1.05
0.036
0.049
Cacng5
-4.77
8.25e-12
2.71e-11
Cacna1g
-3.97
1.53e-08
3.91e-08
Table 1 | Differential expression of calcium channel genes
Log2 (fold change) and p-value calculated to show statistical significance of upregulated (green) and
downregulated genes (red). False discovery rate (FDR) calculated for any type 1 errors. A log2 value of 1
equals a 2-fold change (log base 2 scale).

The channels Cacna2d1 and Cacna1c from the upregulated genes (Table 1) are of
interest because they are L-type voltage gated calcium channels (VGCCs). Orexin is
known to augment Ca influx through L-type Ca2+ channels in the DR and other neurons
(Kohlmeier et al., 2008). Another gene of interest is Cacng3, which is a VGCC. The
protein encoded by Cacng3 is a type I transmembrane AMPA receptor regulatory protein
(TARP). TARPs are known to regulate both trafficking and channel gating of the AMPA
receptors. The next gene of interest is Cacnb1, which is known to regulate the activity of
L-type calcium channels that contain Cacna1a. Genes Cacna2d1, Cacna1c, and Cacna1a
are known to show behavioral/neurological and homeostasis phenotypes (See Appendix
Table 1), and Cacng3 also shows homeostasis phenotypes. The phenotype information for
these genes was obtained in Ensembl.
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D.3 Analysis of Glutamate receptor genes
The heat map (Figure 6) shows at least 9 genes that have higher expression in
serotonergic neurons and at least 9 genes with higher expression in Purkinje neurons,
which is confirmed by the differential expression (Table 2). From the list of upregulated
glutamate genes (Table 2), the ionotropic and metabotropic glutamate receptors with a
direct phenotype in nervous system, were isolated as potential candidate channels (see
Appendix Table 2)), because agonists of glutamate receptors are known to activate orexin
neurons (Li et al., 2002; Yamanaka et al., 2003).
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Figure 6 | Heat map of glutamate receptor genes
Showing gene expression of individual cells of both serotonergic neurons (right) and purkinje neurons (left)
with hierarchical clustering of the neurons (top) and channels (left).
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Gene Name

log (Fold change)

p-value

FDR

Grin2d
6.22
1.37e-18
1.78e-17
Grin2b
5.92
3.15e-30
8.19e-29
Grin1
2.93
3.75e-14
1.95e-13
Grid1
3.81
6.67e-12
2.48e-11
Grm5
5.09
5.25e-11
1.71e-10
Grik5
4.85
4.55e-10
1.18e-09
Gria2
1.43
6.17e-06
1.14e-05
Grik2
3.35
4.69e-05
8.13e-05
Grina
1.20
6.47e-05
0.00011
Grm1
-4.75
1.89e-10
5.45e-10
Grid2
-4.70
1.0061e-13
4.36e-13
Grik1
-4.60
3.50e-17
3.036e-16
Gria3
-3.78
1.79e-06
3.59e-06
Grm2
-3.13
5.20e-08
1.23e-07
Grin2c
-2.95
5.179e-15
3.37e-14
Grm3
-2.53
0.00010
0.00015
Grik3
-2.17
1.039e-07
2.25e-07
Gria1
-1.78
0.0064
0.0092
Table 2 | Differential expression of glutamate receptor genes
Log and p-value calculated to show statistical significance of upregulated (green) and downregulated genes
(red). False discovery rate (FDR) calculated for any type 1 errors. A log value of 1 equals a 2-fold change
(log base 2 scale).

D.4 Analysis of histamine, IP3, ryanodine, and orexin receptor genes
The heat map (Figure 7) shows 4 upregulated and 3 downregulated genes in
serotonergic neurons, which is shown to be statistically significant (Table 3). Hierarchical
clustering (Figure 7) also shows a connection between Hcrtr1, Hcrtr2, Hrh1 and Ryr2.
The upregulated expression of ryanodine receptor 2 (Ryr2) in the DR supports the
finding of Ryanodine receptor involvement in the oeAHP (Ishibashi et al., 2016). The
extremely low Hcrtr1 and Hcrtr2 expression in Purkinje cells fits with the lack of data in
response of Purkinje cells to orexin and the lack of IP3 receptor expression in serotonergic
neurons fits the inability to generate IP3 uncaging in dorsal raphe neurons (Ishibashi et al.,
2016).
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Figure 7 | Heat map of histamine, IP3, ryanodine, and orexin receptor genes
Showing gene expression of individual cells of both serotonergic neurons (left) and Purkinje neurons (right)
with hierarchical clustering of the neurons (top) and receptor genes (left).

Gene Name

log (fold change)

p-value

FDR

Hcrtr1
6.95
1.41e-19
4.69e-19
Hcrtr2
4.31
9.36e-10
2.34e-09
Ryr2
2.19
8.38e-05
0.00017
Hrh3
1.75
0.0058
0.0083
Hrh2
1.25
0.029
0.036
Itpr1
-11.18
1.72e-57
1.72e-56
Ryr1
-6.17
1.32e-21
6.59e-21
Itpr2
-2.54
0.00023
0.00038
Table 3 | Differential expression of histamine, IP3, ryanodine, and orexin receptor genes
Log2 (fold change) and p-value calculated to show statistical significance of upregulated (green) and
downregulated genes (red). False discovery rate (FDR) calculated for any type 1 errors. A log2 value of 1
equals a 2-fold change (log base 2 scale).

D.5 Analysis of TRP channel genes
The heat map (Figure 8) shows very similar gene expression in both serotonergic
and Purkinje neurons, but the differential expression (Table 4) shows 4 upregulated and 5
downregulated genes in serotonergic neurons. There is a discrepancy with the heat map,
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where 5 of the serotonergic neurons are separated from the others. This is because the
heatmap is constructed using hierarchical clustering and the TRP genes have many
differences between them, like being from different sub families and having different
phenotypes attributed to the gene (see Appendix Table 4). The hierarchical clustering
(Figure 8) shows a connection between Trpc7 and Trpv2. It also shows a connection
between Trpc4ap and Trpm7. The high expression of TRPC3 in cerebellar purkinje cells
supports a study done on synaptic transmission and motor coordination. They found that
TRPC3 is a new type of postsynaptic channel that mediates mGluR- dependent synaptic
transmission in cerebellar purkinje cells and that it is crucial for motor coordination
(Hartmann et al., 2008).
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Figure 8 | Heat map of TRP channel genes
Showing gene expression of individual cells of both serotonergic neurons (left) and Purkinje neurons (right)
with hierarchical clustering of the neurons (top) and channels (left).
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Gene Name

log (fold change)

p-value

FDR

Trpv2
3.97
6.060e-10
4.54e-09
Trpc7
3.33
4.84e-08
2.42e-07
Trpm7
1.60
4.23e-05
0.00012
Trpc4ap
1.067
0.0025
0.0054
Trpc3
-6.87
1.73e-20
2.60e-19
Trpm3
-2.036
1.086e-05
4.073e-05
Trps1
-1.76
0.0049
0.0093
Trpm2
-1.34
0.0061
0.010
Trpt1
-1.17
0.0013
0.0032
Table 4 | Differential expression of TRP channel genes
Log2 (fold change) and p-value calculated to show statistical significance of upregulated (green) and
downregulated genes (red). False discovery rate (FDR) calculated for any type 1 errors. A log2 value of 1
equals a 2-fold change (log base 2 scale).

D.6 Analysis of potassium channel genes
The heat map (Figure 9) shows at least 15 genes with upregulation in serotonergic
neurons. Hierarchical clustering (Figure 9) also indicates a connection between these 4
genes. Serotonergic cell 32 is an outlier and it is unclear why it is separate from the other
in the heat map. It could be that the expression of some genes in 5-HT cell 32 are more
similar to some purkinje cells than they are with serotonergic neurons.
Kcnd3 is a channel of interest because it is Kv4.3 channel, which makes an A-type
K+ current that is inhibited by orexin (Ishibashi et al., 2016). It is shown that Kv4.3 mRNA
is differentially expressed (Serôdio & Rudy, 1998), due to that, it is likely that spike
broadening and increased Ca2+ influx results from orexin mediated inhibition of A-current,
mediated by Kv4.3 channels (Ishibashi et al., 2016).
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Figure 9 | Heat map of potassium channel genes
Showing gene expression of individual cells of both serotonergic neurons (right) and purkinje neurons (left)
with hierarchical clustering of the neurons (top) and channels (left).
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Gene Name

log (fold change)

p-value

FDR

Kcnk9
10.78
5.866e-42
2.22e-40
Kcnq3
7.17
4.88e-29
9.27e-28
Kcnn3
7.16
1.93e-21
1.47e-20
Kcnb2
6.27
1.065e-19
5.78e-19
Kcnq2
4.32
3.53e-11
1.12e-10
Kcnc1
3.95
1.20e-16
5.71e-16
Kcnc4
3.89
6.21e-07
1.24e-06
Kcna4
3.54
6.075e-08
1.44e-07
Kcnh2
3.05
2.19e-08
5.57e-08
Kcnq5
2.99
3.91e-07
8.750e-07
Kcnt1
2.72
4.97e-05
9.0018e-05
Kcnab2
1.96
0.00014
0.00022
Kcnd3
1.94
0.00025
0.00037
Kcna2
1.33
0.0014
0.0019
Kcnj3
1.12
0.014
0.017
Kcng4
-7.69
1.43e-24
1.36e-23
Kcnj10
-6.025
7.67e-20
4.86e-19
Kcnc3
-5.79
1.15e-14
4.87e-14
Kcnip3
-5.48
1.026e-25
1.30e-24
Kcnip1
-5.25
1.65e-13
6.28e-13
Kcna1
-5.19
4.84e-13
1.67e-12
Kcnma1
-4.51
9.0054e-09
2.63e-08
Kcnip4
-4.35
1.62e-08
4.40e-08
Kcnab1
-3.94
4.36e-07
9.21e-07
Kcnj16
-2.75
1.38e-05
2.62e-05
Kcnn2
-2.28
7.63e-05
0.00013
Kcnmb4
-2.23
9.11e-05
0.00015
Kcnab3
-2.22
0.00088
0.0012
Kcns2
-2.040
0.0054
0.0071
Kcnq4
-2.038
0.00017
0.00026
Kcnk1
-1.62
0.012
0.015
Table 5 | Differential expression of potassium channel genes
Log2(fold change) and p-value calculated to show statistical significance of upregulated (green) and
downregulated genes (red). False discovery rate (FDR) calculated for any type 1 errors. A log2 value of 1
equals a 2-fold change (log base 2 scale).

D.7 Analysis of Na, K, Ca-dependent, and non-voltage gated ion channel genes
There are nearly 25 genes that show upregulation in serotonergic neurons (Figure
10). All of these genes are statistically significant as shown in the differential expression
(Table 6).
The upregulated solute carrier genes in this group could be potential candidate
genes. Slc6a4 is a 5-HT neurotransmitter transporter that is highly expressed in
serotonergic neurons and absent in Purkinje cells. Another gene of interest is Slc22a17,
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which is a cell surface receptor for lipocalin2 (LCN2) that plays a key role in iron
homeostasis and transport. It is able to bind iron bound LCN2 (holo-24p3), followed by
internalization of holo-24p3 and release of iron, thereby increasing intracellular iron
concentration and leading to inhibition of apoptosis (Bennett et al., 2011). Another
possible candidate is Slc35a22, which is involved in the transport of glutamate (with H+)
across the inner mitochondrial membrane (Goubert et al., 2017).
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Figure 10 | Heat map of Na, K, Ca-dependent, and non-voltage gated ion channel genes
Showing gene expression of individual cells of both serotonergic neurons (right-left) and Purkinje neurons
(middle) with hierarchical clustering of the neurons (top) and ion channels (left).
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Gene Name
Slc6a4

log (fold change)

p-value

FDR

11.88
1.37e-23
1.028e-21
Slc22a3
6.75
8.65e-14
8.0065e-13
Ctif
5.61
1.028e-18
3.80e-17
Usp22
4.23
6.26e-18
1.54e-16
Tcf20
3.92
2.25e-19
1.67e-17
Slc22a17
3.70
1.018e-08
5.38e-08
Trim32
3.65
2.20e-14
2.71e-13
Zdhhc20
3.21
1.21e-10
7.47e-10
Zbtb20
3.14
6.73e-14
7.12e-13
Tomm20
3.12
7.20e-16
1.33e-14
2610507B11Rik
2.91
9.71e-15
1.43e-13
Adam22
2.90
8.56e-12
7.038e-11
Rai1
2.89
6.016e-07
2.782e-06
Usp20
2.89
4.86e-06
1.79e-05
Fbxl20
2.76
3.58e-06
1.39e-05
Slc22a23
2.41
0.00018
0.00056
Tbc1d20
2.14
2.23e-05
7.51e-05
Zdhhc22
2.067
0.00154
0.0033
Fam20b
1.97
0.00073
0.0017
Klhl20
1.73
0.00025
0.00076
Hexdc
1.53
0.00065
0.0016
Klhl22
1.49
0.00051
0.0013
Ncbp2
1.43
0.010
0.017
Rnf20
1.33
0.0032
0.0064
Slc25a22
1.25
0.014
0.024
Phf20
1.16
0.030
0.049
Slc20a2
-4.36
2.15e-10
1.22e-09
Slc22a4
-3.99
9.30e-11
6.26e-10
Nudt22
-3.62
7.97e-11
5.90e-10
Snx24
-3.15
2.0061e-07
9.89e-07
Med22
-2.95
7.51e-07
3.27e-06
Naa20
-2.94
2.013e-06
8.27e-06
Pcdhb20
-2.66
1.29e-05
4.57e-05
Vmn2r20
-2.23
9.80e-05
0.00031
Cdh22
-2.22
0.00032
0.00092
Smim20
-2.15
0.00081
0.0018
Arhgap20
-2.021
0.00077
0.0017
Lrrc20
-1.96
0.00066
0.0016
Cfap20
-1.83
0.012
0.022
Mettl22
-1.77
0.0037
0.0073
Wdr20
-1.68
0.0046
0.0088
Timm22
-1.65
0.0020
0.0043
Gpr22
-1.65
0.0081
0.014
Cyp20a1
-1.63
0.0022
0.0045
H2-T22
-1.56
0.0076
0.014
Rgs20
-1.51
0.00050
0.0013
Faap20
-1.38
0.022
0.037
Table 6 | Differential expression of Na, K, Ca-dependent, and non-voltage gated ion channel genes –
showing statistical significance
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D.8 Analysis of Na or Ca-dependent, non-voltage gated ion channels
The heatmap (Figure 11) and the differential expression (Table 7) show 20 genes
that are upregulated in serotonergic neurons and 11 genes that are downregulated. The
hierarchical clustering (Figure 11) shows a connection between Nalcn and Trpm7, Grin2b,
and Slc1a4. Hcn3 is a potential candidate because it is a hyperpolarization activated
potassium channel. It may also facilitate the permeation of sodium ions. It is also inhibited
by cesium (Negrini et al., 2016) and ZD7288 (Wu et al., 2012).
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Figure 11 | Heat map of Na or Ca-dependent non-voltage gated ion channels.
Showing gene expression of individual cells of both serotonergic neurons (left) and Purkinje neurons (right)
with hierarchical clustering of the neurons (top) and ion channels (left).

43

Gene Name

log (fold change)

p-value

FDR

Hcn3
7.63
7.88e-29
1.89e-27
Grin2d
6.21
5.87e-19
5.64e-18
Grin2b
5.91
1.096e-29
5.26e-28
Grm5
5.091
2.74e-11
1.46e-10
Grik5
4.85
2.51e-10
1.20e-09
Slc1a4
4.75
8.25e-17
5.65e-16
Trpv2
3.97
4.70e-10
1.88e-09
Panx1
3.93
4.52e-10
1.88e-09
Grik2
3.35
3.51e-05
7.66e-05
Trpc7
3.33
4.24e-08
1.45e-07
Asic2
2.95
1.27e-06
3.81e-06
Pkd1
2.94
2.30e-05
5.52e-05
Grin1
2.93
1.48e-13
8.89e-13
Nalcn
2.38
1.79e-06
5.078e-06
Slc24a2
2.22
7.20e-06
1.92e-05
Pdk1
1.78
0.0025
0.0045
Trpm7
1.60
7.060e-05
0.00014
Gria2
1.43
1.52e-05
3.85e-05
Asic4
1.14
0.0090
0.015
Catsper4
1.031
0.018
0.028
Scn4b
-7.51
5.37e-27
8.59e-26
Trpc3
-6.87
7.10e-21
8.52e-20
Grik1
-4.60
3.49e-17
2.79e-16
Kcnma1
-4.51
1.066e-08
3.93e-08
Kcnn2
-2.28
6.77e-05
0.00014
Grik3
-2.17
1.71e-07
5.48e-07
P2rx4
-2.11
3.42e-05
7.66e-05
Slc24a5
-2.096
0.0022
0.0040
Kcnk1
-1.62
0.012
0.019
P2rx7
-1.54
0.00047
0.00091
Trpm2
-1.34
0.0066
0.011
Table 7 | Differential expression of Na or Ca-dependent non-voltage gated ion channel genes.
Log2 (fold change) and p-value calculated to show statistical significance of upregulated (green) and
downregulated genes (red). False discovery rate (FDR) calculated for any type 1 errors. A log2 value of 1
equals a 2-fold change (log base 2 scale).

D.9 Analysis of potential candidate genes
After the breakdown and analysis of multiple groups of genes, we isolated potential
genes that were highly expressed in serotonergic neurons and displayed some properties
that might mediate orexin neuropeptide action on serotonergic neurons. Isolating channels
from each group analyzed, we compiled a group of channels to do scRNA-seq analysis on.
These are potential channels that might exhibit novel effects which both excites the
neurons and alters their firing pattern by lengthening the spike afterhyperpolarization
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(Ishibashi et al., 2016). The goal is to find cells with high SK3 expression and cation
channels that are not directly gated by ligand, but gated by second messengers, in
particular protein kinase C (PKC) activation. Also, these channels should not be blocked
by extracellular cesium but inhibited by extracellular and intracellular Ca2+.
The first channel of interest is Kcnn3, which is a small-conductance calciumactivated potassium channel (SK3). A few channels who have similar expression to Kcnn3
are Cacna1a, Nalcn, Hcn3, and Trpc4ap. All these channels seem to have a similar gene
expression profiles, as seen by the hierarchical clustering (Figure 12) of the DR and MR
serotonergic neurons. Kcnn3 also shows function at the plasma membrane (see Appendix
Table 5). It has been shown that PKC enhances plasma membrane expression of cardiac
L-type calcium channels (Hofmann, 2018; Raifman et al., 2017). So, channels with
function at plasma membrane and/or relation to cardiovascular system, could indicate that
the channel might be activated by PKC or at least could has some relationship to PKC.
Other genes that have shown function in the plasma membrane and are related to
the cardiovascular system are Cacna2d1, Cacna1b, Cacna1c (see Appendix Table 1),
Grin2d, Grin1 (See Appendix Table 2), Ryr2 (see Appendix Table 3), Trpc6 (see
Appendix Table 4), Slc6a4 (see Appendix Table 6), Hcn3, and Asic4 (see Appendix
Table 7). Another possibility is a combination of Trpc3, Trpc6, and Trpc7. These channels
hetero-multimerize and exhibit the right properties. A concern here is that Trpc6 does not
seem to show any expression in serotonergic neurons or Purkinje neurons. Ultimately, the
channel chosen was Nalcn, which was differentially expressed in the serotonergic neurons
and it has the possibility that it might mediate the several novel effects of orexin that have
been described.
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Slc6a4
Slc22a3
Kcnk9
Cacna1e
Kcnq3
Grin2b
Cacng3
Cacna2d1
Cacna1b
Grin1
Kcnd3
Cacna1a
Slc25a22
Trpm7
Nalcn
Trpc4ap
Asic2
Kcnq2
Slc22a23
Ryr2
Cacna1c
Slc22a17
Slc1a4
Grid1
Trpc3
Asic4
Trpc7
Hcrtr2
Kcnq5
Hcn2
Panx1
Trpv2
Grm5
Cacnb1
Kcnn3
Hcn3
Hcrtr1
Grin2d
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5HT_16(DR)
5HT_14(DR)
5HT_9(DR)
5HT_4(DR)
5HT_8(DR)
5HT_2(DR)
5HT_26(MR)
5HT_1 (DR)
5HT_31(MR)
5HT_19(MR)
5HT_11(DR)
5HT_28(MR)
5HT_20(MR)
5HT_30(MR)
5HT_22(MR)
5HT_18(MR)
5HT_27(MR)
5HT_21(MR)
5HT_23(MR)
5HT_12(DR)
5HT_7(DR)
5HT_6(DR)
5HT_15(DR)
5HT_13(DR)
5HT_29(MR)
5HT_17(MR)
5HT_25(MR)
5HT_5(DR)
5HT_32(MR)
5HT_3(DR)
5HT_10(DR)
5HT_24(MR)
P_20
P_19
P_31
P_22
P_21
P_6
P_5
P_30
P_29
P_13
P_11
P_18
P_17
P_10
P_9
P_28
P_27
P_2
P_1
P_4
P_3
P_26
P_24
P_16
P_15
P_8
P_14
P_12
P_7
P_25
P_23
P_32

Figure 12 | Heat map of potential candidate genes – both 5-HT and Purkinje cells
Showing gene expression of individual cells of both serotonergic neurons (right) and Purkinje neurons (left)
with hierarchical clustering of the neurons (top) and channel genes (left).
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Slc6a4
Cacna1e
Kcnk9
Kcnq3
Grin1
Grin2b
Cacna2d1
Cacna1b
Trpc3
Asic4
Slc22a3
Slc22a23
Grm5
Ryr2
Grin2d
Asic2
Hcrtr1
Trpm7
Grid1
Slc22a17
Slc25a22
Cacna1c
Slc1a4
Cacna1a
Kcnn3
Cacnb1
Nalcn
Hcn3
Trpc4ap
Cacng3
Kcnq2
Kcnd3
Trpc7
Hcrtr2
Kcnq5
Hcn2
Panx1
Trpv2
5HT_16(DR)
5HT_14(DR)
5HT_9(DR)
5HT_4(DR)
5HT_8(DR)
5HT_2(DR)
5HT_26(MR)
5HT_1 (DR)
5HT_31(MR)
5HT_19(MR)
5HT_11(DR)
5HT_28(MR)
5HT_20(MR)
5HT_30(MR)
5HT_22(MR)
5HT_18(MR)
5HT_27(MR)
5HT_21(MR)
5HT_23(MR)
5HT_12(DR)
5HT_7(DR)
5HT_6(DR)
5HT_15(DR)
5HT_13(DR)
5HT_29(MR)
5HT_17(MR)
5HT_25(MR)
5HT_5(DR)
5HT_32(MR)
5HT_3(DR)
5HT_10(DR)
5HT_24(MR)

Figure 13 | Heat map of potential candidate genes – 5-HT only
Showing gene expression of individual cells of serotonergic neurons with hierarchical clustering of the
neurons (top) and gens (left).
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Aim 2: Testing a candidate ion channel
D.10 Expression of Nalcn
The list of potential channels has been narrowed down to 17 genes from a few
hundred. From those 17 genes, only 7 are upregulated in Serotonergic neurons vs Purkinje
cells. One of those upregulated channels in DR 5-HT neurons is Nalcn, which is a sodium
leak channel that is modulated by GPCRs and also inhibited by extracellular [Ca2+].
Our first step of testing this channel was to confirm Nalcn protein is expressed in
DR 5-HT neurons. To do that, we sought to determine an effective concentration of a
commercially available anti-Nalcn antibody by exploring both a highly sensitive VIP
immunocytochemistry approach and an indirect immunofluorescence approach to visualize
immunoreactivity. Then we used this antibody to determine whether there was Nalcn
immunostaining in the DR and whether there was Nalcn present in serotonergic neurons.
Since our ultimate goal is to knock out the channel to test its role in mediating orexin
responses, we next wanted to confirm that we could detect Nalcn protein in the DR of mice
with the Nalcn gene floxed (NalcnFL/FL). We first confirmed a normal expression pattern of
5-HT neurons in NalcnFL/FL mice using an antibody to TPH (the rate-limiting enzyme in 5HT biosynthesis). We then determined if Nalcn expression could be detected in these
neurons. After that, our goal was to determine whether we could block Nalcn
immunostaining in DR neurons by expressing Cre- recombinase in the DR delivered by
microinjection of a viral vector (AAV) at different time points prior to conducting
immunocytochemistry.
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D.11 Finding an effective concentration of the anti-Nalcn antibody (#ASC-022)
VIP immunohistochemistry was selected because it is generally more sensitive than
immunofluorescence and ion channels, which are low abundance proteins are very
challenging to reliably visualize with immunocytochemistry. Moreover, the commercially
available antibody, which was made to an extracellular domain of the channel protein, has
not been published. We therefore tested different concentrations of the antibody. We tested
[1:1000] (Figure 14A), [1:500] (Figure 14B) and [1:200] dilutions. Nalcn staining with
these concentrations from the VIP done was not convincing since the VIP reaction required
long durations and produced significant background staining that was observed in appeared
cell nuclei, which are not expected to contain authentic staining. We tried to improve the
VIP immunohistochemistry by using [1:200] (Figure 14C) with some altered conditions.
Instead of 1-day incubation with the primary antibody, tissue was incubated for 2 days at 4
degrees Celsius with agitation. This was because with 1 day incubation there wasn’t
sufficient Nalcn staining visible. Also, the ethanol and xylene wash steps were also
reduced by half, in case that was causing a reduction in staining. These changes improved
the results but not by much. At last, the VIP was repeated using a higher concentration
[1:100 dilution] of the primary antibody (Figure 14D), which improved the results, and the
staining could be properly visualized with reaction product on neuronal membranes and
less apparent non-specific staining of nuclei.

49

A

B

C

D

Figure 14 | Expression of Nalcn at different concentrations of Nalcn antibody
(A) VIP using [1:1000] of Nalcn antibody with an exposure time of 3.5 mins. (B) VIP using [1:500] of Nalcn
antibody with an exposure time of 2 mins. (C) VIP using [1:200] of Nalcn antibody with an exposure time of
1 min. (D) VIP using [1:100] of Nalcn antibody with an exposure time of 1 min. This was done using VIP
Immunohistochemistry with Anti Nalcn/VGCNL1 (extracellular) antibody. The white arrows are indicating
the Nalcn expression due to the extracellular antibody at [1:100]. The location of these images was superior
to the aqueduct. The images were taken with 60x objective. The scale bar is 50um.

D.12 Nalcn immunostaining in TPH+ DR neurons in Sert-Cre/dTom mice
The next series of experiments we wanted to determine whether Nalcn was present
in the Dorsal Raphe and whether it could be visualized in 5-HT neurons. For this we
wanted to use double labelling which is generally more successful if it can be done with
fluorescence tags. Surprisingly, the Nalcn immunofluorescence seemed more reliable than
the VIP staining, in that the background between the cells was lower and there was little
apparent nuclear staining (Figure 15). Success with immunofluorescence allowed us to use
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Sert-Cre/dTom mice (Figure 15) which express bright red fluorescence selectively in 5HT neurons in the DR (Li et al., 2016; Ren et al., 2019). By doing immunohistochemistry
on Sert-Cre: dTom mice, it was confirmed that Nalcn immunostaining was present in the
DR (Figure 15).

Figure 15 | Expression of Nalcn in the DR of Sert-Cre/dTom mice.
Expression of Nalcn in Sert-Cre/dTom mice using [1:100] Nalcn antibody and Alexa Fluor 488. These
images were taken with 40x Objective.

After confirming Nalcn Immunostaining in the DR, we needed to determine if there
was expression of Nalcn in serotonergic neurons. This was done using
Immunohistochemistry. We did immunohistochemistry using [1:100] of Nalcn antibody
and Alexa Fluor 488 on Sert-Cre/dTom mice. It was clearly visible from the superimposed
image that Nalcn immunostaining is present in dTom fluorescent neurons (Figure 16C). It
is also apparent from this image that some Nalcn immunopositive neurons are not dTom
positive (Figure 16 open arrows), suggesting that some non-serotonergic neurons also
express Nalcn protein.
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Figure 16 | Expression of Nalcn in Serotonergic Neurons of the DR
(A) Expression of serotonergic neurons in the DR of a Sert Tom + mouse. (B) Expression of Nalcn in the DR
of a Sert Tom + mouse. (C) Overlap of the expression of serotonergic neurons and Nalcn. These images were
taken using a 40x objective. Open arrows show Nalcn immunopositive neurons are not dTom positive.
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D.13 Expression of TPH in the NalcnFL/FL mice
Since we were using NalcnFL/FL mice, it was important to determine that we
could detect Nalcn in the DR of these mice and that there was normal expression of
serotonergic neurons in the Dorsal raphe of these mice. Immunostaining in the NalcnFL/FL
mice (Figure 17) showed that we could still detect Nalcn immunofluorescence in these
engineered mice. Nevertheless, our subjective impression was that cellular definition was
less clear in sections from these mice, although the reason for this is not clear. To confirm
that 5-HT neurons were normally distributed in these mice we used anti-Tph as the
primary antibody and Alexa Fluor 594 was used as the secondary antibody. The TPH
immunofluorescence in the NalcnFL/FL (Figure 18A) was compared with that in C57Blk6
mice (Figure 18B). It was clear by the immunohistochemistry results that TPH+ neurons
in NalcnFL/FL mice had shapes and distributions that were qualitatively similar to what we
observed in the C57Blk6 mice.

Figure 17 | Expression of Nalcn in the DR of NalcnFL/FL
Expression of Nalcn in NalcnFL/FL mice using Nalcn antibody and Alexa Fluor 594.
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Figure 18 | Serotonergic Neurons in NalcnFL/FL and wildtype C57Blk6 appeared similar in shape and
distribution.
(A) Expression of Serotonergic Neurons in the DR of NalcnFL/FL. (B) Expression of Serotonergic Neurons in
the DR of Blk6. These images were taken using a 20x objective.

D.14 Determining if Cre expression blocks Nalcn immunostaining
The next goal was to reduce or knock out the expression of Nalcn from the DR.
The NalcnFL/FL mice used were from the Jackson laboratory, in which Exons 5 and 6 of the
mouse Nalcn gene are flanked by the loxP sites (Yeh et al., 2017). This allows Cremediated excision of the floxed region resulting in a knock-out allele. NalcnFL/FL mice
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were injected with an AAV9 virus carrying Cre-recombinase (Addgene plasmid # 49056)
with a human synapsin promoter to limit expression to neurons (Gompf et al., 2015). After
waiting 4 weeks for the virus to express, our preliminary inspection of wide field
fluorescence images, revealed clear Cre-driven EGFP fluorescence in the nuclei of neurons
in the injected region. Two mice were injected off target with Cre being expressed in above
the DR in the central gray and above that in the colliculi. Since Nalcn is expressed through
the brain, immunohistochemistry was done to determine whether Nalcn expression was
reduced in the area where Cre was expressed. Nalcn immunofluorescence did not appear to
be strongly suppressed in the Cre-expressing regions. While some cells expressing Crerecombinase, had little cytoplasmic staining for Nalcn, while other cells with Creexpression showed substantial Nalcn staining. Since Nalcn, like other ion channels are
expressed at rather low levels, we will next re-image the tissue sections to improve
detectability of cellular fluorescence with the goal of counting the fraction of Cre-positive
cells expressing Nalcn and compare this with the fraction of Cre-negative cells expressing
Nalcn.
Afterwards, 3 more NalcnFL/FL mice were injected with the AAV9-Cre virus. The
Duration of Cre expression was different in each mouse, so we could see if longer
exposure to Cre would provide better results since we are not sure how stable the Nalcn
protein is which will dictate how long we need to wait before it is no longer present. Cre
was expressed in the NalcnFL/FL mice for 4, 6 and 8 weeks, before the mice were perfused.
In the mice, in which Cre was expressed for 6 and 8 weeks, there was successfully
expression with Cre expression in the Dorsal Raphe (Figure 19A). However, even with the
8-week Cre expression, we saw the same pattern of Cre+ cells with Nalcn
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immunoreactivity and other Cre+ cells without Nalcn immunoreactivity (Figure 19B).
This could mean that antibody staining is not reflecting the Nalcn protein levels or that the
half-life of the channels is extremely long. To determine that we are actually knocking
down Nalcn mRNA expression, in future experiments we will prepare tissue punches from
AAV-injected mice, centered on the injection (determined by Cre-fluorescence) and
adjacent regions to compare Nalcn mRNA levels by qRT-PCR.
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Figure 19 | Cre expression produced by AAV9-hSyn-eGFP-Cre microinjection in NalcnFL/FL 8-weeks
after microinjection
(A) nuclear expression of EGFP-Cre extends into the DR (10x obj). (B) Higher magnification of EGFP-Cre
expression in the DR (60x obj). (C) Nalcn immunostaining in the DR. (D) Merge of EGFP-Cre and Nalcn
immunostaining. In B-D, the white solid arrows indicate some cells with EGFP nuclei and Nalcn
immunostaining. Yellow arrow heads indicate cells with EGFP-Cre+ and no Nalcn+ cytoplasm; Open white
arrows indicate Nalcn+ cytoplasm lacking EGFP-Cre+ nuclei.
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Discussion
Based on function expression studies, many genes code for subunits that form
functional ion channels with properties similar to the cation channel effectors in 5-HT DR
neurons. These include many members of the Trp superfamily of ion channels and the
Nalcn channel. Purkinje neurons were chosen for comparison, because despite having
different electrical properties and no reported direct orexin responses, they have several
types of cation permeable ion channels. Half the serotonergic neurons analyzed were
obtained from the median raphe (MR) and half from the dorsal raphe. This was done to get
a wider range of genes expressed by 5-HT neurons and because DR and MR containing
neurons have similar responses to orexin. This was confirmed when we saw a similar
expression pattern of most genes in the dorsal and median raphe neurons. In the last year
more sets of scRNA-seq data from just the DR have been made available so it will be
interesting to re-run this analysis with more 5-HT DR cells to see if other subunits are
detected from a wider pool of cells.
Initially, the gene expression profile of 30,244 genes were analyzed. We then used
the AmiGO2 database to construct a broad list of channel genes that might be influenced
by orexin receptor activation and performed single cell RNA sequence analysis on each
group. After analyzing the gene expression profiles of multiple groups of channels, we
isolated 39 genes (Figure 12) that we thought could be potential candidates based on their
novel orexin actions. One thing we noted was that there was a clear distinction between
serotonergic neurons and cerebellar Purkinje neurons based on the gene expression profiles
of the selected channels, which could be visualized by the tSNE plot (Figure 4). These
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differences likely contribute to the underlying electrophysiological differences between
these cell types.
Several interesting channels were noted including the Asic channels, which were
differentially expressed in DR neurons and are cation channels. Panx1 is another channel
of interest, which makes a massive conductance single channel that is permeable to all
kinds of things including small second messenger molecules like adenosine. Another
channel of interest was the Kcnd3 or Kv.4.3 channel, which was highly expressed in the
DR. These channels produce an A-type K+ current and is the likely identity of the orexin
inhibited A-current that was previously described in DR neurons (Ishibashi et al, 2016) and
other GPCRs in other cells, including dopamine cells (Gantz & Bean, 2017).
The next group of channels we consider candidates for the orexin activated cation
channel included TRPC3, 6, and 7. It is known that Trpc3, 6, and 7 that can heteromultimerize and form functional channels. Even though Trpc3 is more differentially
expressed in Purkinje cells on average than it is in the raphe neurons and Trpc6 isn’t
expressed much in either neurons, it is possible that Trpc7 is forms homomeric channels,
which could account for the current we have seen following orexin application. One
appeal of TRPC channels is that produce very noisy currents which would fit with the
noisiness we see when the cation current gets turned on by orexin and the decreasing noise
during the oeAHP. Another interesting thing is that they are known to be inhibited by
intracellular calcium. One potential problem with this idea is that the TRPC channels are
calcium permeable, which has been difficult to demonstrate in DR neurons (Kohlmeier et
al., 2008).
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Given the many possible candidates we chose to first test Nalcn. This decision was
based on our previous laboratory research done on orexin actions on DR neurons. Nalcn is
part of a complex which includes GPCRs and might be considered a GPCR-activated
channel (Cochet-Bissuel et al., 2014). Since orexin receptors can efficiently couple to PLC
(Kukkonen & Leonard, 2013) it is possible that Nalcn is one effector. Nalcn is also highly
sodium selective and doesn’t effectively permeate calcium as suggested for the orexin
current in DR (Kohlmeier et al., 2008). Nalcn is also inhibited by extracellular calcium
(Lee et al., 2019) at above physiological levels, which is similar to the current that is
activated by Orexin (Ishibashi and Leonard, unpublished observations). Finally, the
availability of NalcnFL/FL mice and a possible antibody for Nalcn were also factors in
selecting Nalcn as the first candidate to test.
Using a [1:100] dilution of anti-Nalcn antibody we found Nalcn immunostaining in
serotonergic neurons of the DR in Sert-Cre/dTom mice (Figure 16C). From this we might
conclude this is convincing immunocytochemistry supporting the idea that Nalcn is
expressed in serotonergic neurons among other neurons of the DR.
To further test this idea, we attempted to knock out Nalcn expression by expressing
Cre into the DR of mice that have the Nalcn gene floxed. We saw that the Cre expression
was nuclear in nature based on the EGFP tag, suggesting it was properly expressed at our
target sites. However, there did not appear to be the expected dramatic loss of Nalcn
immunofluorescence. This suggests that the channel protein is either persistent for more
than 8 weeks following injection or the immunostaining, or that the immunofluorescence is
not reflecting Nalcn protein levels.
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To further explore this, we can try expressing Cre in NalcnFL/FL mice for longer
than 8 weeks to see if there is a reduction of Nalcn immunofluorescence. We can check
also the message levels to see if there is a reduction Nalcn mRNA. Finally, we can try
additional antibodies or use whole cell patch clamping in brain slices to functionally test if
Nalcn is functionally absent in cells expressing Cre-EGFP in DR neurons. Assuming we
can prove we have knocked out the channel we can then use patch clamp methods to
determine if orexin still has its complex actions in the absence of Nalcn. Of course, it is
possible that Nalcn is not the correct channel, in which case, this same approach can be
performed with another candidate channel identified using bioinformatics, such as Trpc7.
Assuming we can demonstrate a knock-down of Nalcn, we will then use whole cell
patch clamping in brain slices to functionally test if Nalcn is the channel that mediates the
Orexin A action on serotonergic neurons of DR. It is possible that Nalcn is not the correct
channel, in which case, this same approach can be performed with another candidate
channel identified using bioinformatics (e.g., Trpc3/7). Even if Nalcn is not the channel
that mediates the Orexin A action, it is likely that a 5-HT neuron specific knockout of
Nalcn will affect the resting potential of DR-5-HT neurons. Further studies could be done
to see the behavioral differences in the mice with Nalcn KO in these Serotonergic neurons
of the DR.
We also noticed some limitations of this approach. We saw in the gene expression
that Purkinje neurons appear not to have orexin (Hcrt) expression (Figure 12), so it is
possible that the relevant channel is expressed in both cell types but is not activated by
orexin in Purkinje cells. If this is the case, these cells wouldn’t be detected by this analysis.
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The channel we choose to test, Nalcn, does have some expression in Purkinje cells but it’s
not enough to be a significant upregulation.
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Appendix
Gene
name

Description

Phenotype
Overview

Molecular
function

Biological
process

Cellular
component

Cacna2d1

VGCC,
alpha2/delta
subunit 1

Behavior/neurological,
homeostasis/metabolism,
muscle, cardiovascular,
hematopoietic, renal/urinary
and nervous system

Transporter

endoplasmic
reticulum,
plasma
membrane,
synapse

Cacna1b

pore forming,
VGCC, N type,
alpha 1B subunit

carbohydrate
derivative binding,
transporter

Cacna1e

pore forming,
VGCC, R type,
alpha 1E subunit

Behavior/neurological,
growth/size/body,
homeostasis/metabolism,
integument, mortality/aging,
cardiovascular and nervous
system
Behavior/neurological,
endocrine/exocrine glands,
growth/size/body,
homeostasis/metabolism,
nervous system

establishment of
localization,
homeostatic
process, response
to stimulus,
signaling
establishment of
localization,
response to
stimulus,
signaling

plasma
membrane,
synapse

Cacng3

VGCC, gamma
subunit 3

homeostasis/metabolism

Signaling receptor
binding, transporter

Cacna1c

VGCC, L type,
alpha 1C subunit

cytoskeletal protein
binding, transporter

Cacnb1

VGCC, beta 1
subunit

behavior/neurological,
cellular, craniofacial,
embryo, endocrine/exocrine
glands, growth/size/body,
homeostasis/metabolism,
integument, mortality/aging,
muscle, hematopoietic,
immune, cardiovascular and
nervous system
behavior/neurological,
limbs/digits/tail,
mortality/aging muscle,
skeleton

Cacna1a

Pore forming,
VGCC, P/Q type,
alpha 1A subunit

behavior/neurological,
cellular, endocrine/exocrine
glands growth/size/body,
homeostasis/metabolism,
integument, mortality/aging,
muscle, immune,
hematopoietic, reproductive,
respiratory, and nervous
system

transporter

establishment of
localization,
homeostatic
process, response
to stimulus,
signaling
establishment of
localization,
response to
stimulus,
signaling
establishment of
localization,
homeostatic
process, immune
system process,
response to
stimulus,
signaling, system
development
cellular
component
organization,
establishment of
localization,
response to
stimulus,
signaling
cell death, cell
differentiation,
cellular
component
organization,
establishment of
localization,
homeostatic
process, response
to stimulus,
signaling, system
development

transporter

transporter

Cell projection,
plasma
membrane,
synapse

Cell projection,
plasma
membrane,
synapse
Cell projection,
non-membranebounded
organelle, plasma
membrane,
synapse

endoplasmic
reticulum,
plasma
membrane,
synapse

Cell projection,
nucleus, plasma
membrane,
synapse

Table 1 | Description of potential candidate Ca2+ genes
The phenotype overview column indicates any direct phenotypes attributed to mutations/alleles of the gene.
Green labels indicate potential candidate genes with novel orexin actions. The cellular component refers to
the location relative to cellular structures in which the channel performs a function. All data was obtained
from Ensembl and mouse genome informatics database.
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Gene
name

Description

Phenotype
overview

Molecular
function

Biological process

Cellular
component

Grin2d

glutamate
receptor,
ionotropic,
NMDA2D
(epsilon 4)
glutamate
receptor,
ionotropic,
NMDA2B
(epsilon 2)

behavior/neurological
cardiovascular system,
growth/size/body,
homeostasis/metabolism,
skeleton
behavior/neurological,
mortality/aging,
growth/size/body,
homeostasis/metabolism,
nervous system

Signaling receptor
activity,
transporter

establishment of
localization, homeostatic
process, response to
stimulus, signaling

Plasma membrane,
synapse

signaling receptor
activity, signaling
receptor binding,
transporter

cell projection,
cytoplasmic vesicle,
cytoskeleton, endosome,
extracellular region, nonmembrane-bounded
organelle, plasma
membrane, synapse,
vacuole

Grin1

glutamate
receptor,
ionotropic,
NMDA1 (zeta 1)

signaling receptor
activity, signaling
receptor binding,
transporter

Grid1

glutamate
receptor,
ionotropic, delta 1
glutamate
receptor,
metabotropic 5

behavior/neurological,
cardiovascular system,
cellular,
growth/size/body,
hearing/vestibular/ear,
hematopoietic system,
homeostasis/metabolism,
mortality/aging,
reproductive system,
respiratory system,
nervous system
growth/size/body,
hearing/vestibular/ear,
skeleton, nervous system
adipose tissue,
behavior/neurological,
growth/size/body,
integument, nervous
system

Cell death, cellular
component organization,
establishment of
localization, homeostatic
process, protein
metabolic process,
response to stimulus,
signaling, system
development
Cell death, cell
differentiation, cellular
component organization,
establishment of
localization, homeostatic
process, nucleic acidtemplated transcription,
protein metabolic
process, response to
stimulus, signaling,
system development
establishment of
localization, signaling
cell differentiation,
cellular component
organization,
establishment of
localization, nucleic acidtemplated transcription,
protein metabolic
process, response to
stimulus, signaling,
system development
Cell death, cellular
component organization,
establishment of
localization, response to
stimulus, signaling
cellular component
organization,
establishment of
localization, response to
stimulus, signaling

Cell projection, plasma
membrane, synapse

Cell death, establishment
of localization,
homeostatic process,
response to stimulus,
signaling

Cell projection, plasma
membrane, synapse

Grin2b

Grm5

signaling receptor
activity,
transporter
signaling receptor
activity, signaling
receptor binding

Grik5

glutamate
receptor,
ionotropic, kainate
5

behavior/neurological,
integument, nervous
system

signaling receptor
activity,
transporter

Gria2

glutamate
receptor,
ionotropic,
AMPA2 (alpha 2)

cytoskeletal
protein binding,
signaling receptor
activity, signaling
receptor binding,
transporter

Grik2

glutamate
receptor,
ionotropic, kainate
2 (beta 2)

behavior/neurological,
cellular,
growth/size/body,
homeostasis/metabolism,
integument,
mortality/aging, nervous
system
behavior/neurological,
growth/size/body,
nervous system

signaling receptor
activity,
transporter

cell projection,
cytoplasmic vesicle,
endoplasmic reticulum,
extracellular region,
plasma membrane,
synapse

Plasma membrane,
synapse

Cell projection,
endoplasmic reticulum,
nucleus, organelle lumen,
plasma membrane,
synapse
cell projection,
cytoplasmic vesicle,
endoplasmic reticulum,
extracellular region,
plasma membrane,
synapse

Table 2 | Description of potential candidate glutamate genes
The phenotype overview column indicates any direct phenotypes attributed to mutations/alleles of the gene.
Green labels indicate potential candidate genes with novel orexin actions. The cellular component refers to
the location relative to cellular structures in which the channel performs a function. All data was obtained
from Ensembl and mouse genome informatics database.
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Gene
name

Description

Phenotype

Molecular
Function

Biological
process

Cellular
component

Hcrtr1

hypocretin (orexin)
receptor 1

behavior/neurological,
nervous system

Signaling
receptor activity

Plasma membrane

Hcrtr2

hypocretin (orexin)
receptor 2

behavior/neurological,
muscle, nervous system

Signaling
receptor activity

Ryr2

ryanodine receptor
2

behavior/neurological,
cardiovascular system,
embryo,
endocrine/exocrine
glands, growth/size/body,
hematopoietic system,
homeostasis/metabolism,
immune system,
mortality/aging, muscle,
nervous system

Transporter

Homoeostatic
process, response to
stimulus, signaling
Homoeostatic
process, response to
stimulus, signaling
Cell death,
establishment of
localization,
homeostatic
process, response to
stimulus, signaling,
system development

Plasma membrane
cell projection,
cytoplasmic vesicle,
endoplasmic
reticulum, nonmembrane-bounded
organelle, nucleus,
organelle envelope,
plasma membrane

Table 3 | Breakdown of potential candidate hypocretin and ryanodine genes
The phenotype overview column indicates any direct phenotypes attributed to mutations/alleles of the gene.
Green labels indicate potential candidate genes with novel orexin actions. The cellular component refers to
the location relative to cellular structures in which the channel performs a function. All data was obtained
from Ensembl and mouse genome informatics database.
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Gene
name

Description

Phenotype
overview

Molecular
Function

Biological
process

Cellular
component

Trpv2

transient receptor
potential cation
channel, subfamily
V, member 2

Cellular,
growth/size/body,
hematopoietic system,
immune system,
mortality/aging

Transporter

Cell projection,
plasma
membrane

Trpc7

transient receptor
potential cation
channel, subfamily
C, member 7
transient receptor
potential cation
channel, subfamily
M, member 7

Vision/eye

Transporter

cell differentiation,
cell population
proliferation, cellular
component
organization,
establishment of
localization,
homeostatic process,
response to stimulus,
system development
establishment of
localization,
homeostatic process

behavior/neurological,
cellular,
digestive/alimentary
system, embryo,
endocrine/exocrine glands,
growth/size/body,
hematopoietic system,
homeostasis/metabolism,
immune system,
integument,
mortality/aging, nervous
system, pigmentation,
renal/urinary system,
vision/eye
integument

carbohydrate
derivative binding,
cytoskeletal
protein binding,
transferase,
transporter

Cell death, cellular
component
organization,
establishment of
localization,
homeostatic process,
protein metabolic
process

cell projection,
cytoplasmic
vesicle, plasma
membrane,
synapse

N/A

protein metabolic
process, system
development

N/A

behavior/neurological,
growth/size/body,
hematopoietic system,
immune system,
mortality/aging,
vision/eye, nervous
system
behavior/neurological,
cardiovascular system,
homeostasis/metabolism,
integument, muscle,
renal/urinary system,
vision/eye

Transporter

establishment of
localization,
homeostatic process,
response to stimulus

Plasma
membrane

cytoskeletal
protein binding,
transporter

cell differentiation,
cellular component
organization,
establishment of
localization,
homeostatic process,
protein metabolic
process response to
stimulus, system
development

Plasma
membrane

Trpm7

Trpc4ap

Trpc3

Trpc6

transient receptor
potential cation
channel, subfamily
C, member 4
associated protein
transient receptor
potential cation
channel, subfamily
C, member 3

transient receptor
potential cation
channel, subfamily
C, member 6

Golgi apparatus,
nucleus, plasma
membrane

Table 4 | Breakdown of potential candidate TRP genes
The phenotype overview column indicates any direct phenotypes attributed to mutations/alleles of the gene.
All data was obtained from Ensembl and mouse genome informatics database. Green labels indicate potential
candidate genes with novel orexin actions. Trpc6 is included because it forms heterodimer with Trpc3 and
Trpc7.
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Gene
name

Description

Phenotype

Molecular
function

Biological
process

Cellular
component

Kcnk9

potassium channel,
subfamily K, member
9, task 3
potassium voltagegated channel,
subfamily Q, member
3, M-current subunit

Nervous system

transporter

establishment of
localization

behavior/neurological,
craniofacial,
growth/size/body,
homeostasis/metabolism,
mortality/aging, nervous
system
reproductive system
respiratory system,
mortality/aging, nervous
system

transporter

establishment of
localization,
response to
stimulus

cytoplasmic
vesicle, plasma
membrane, synapse
cell projection,
plasma membrane

Transporter

establishment of
localization

cell projection,
plasma membrane,
synapse

behavior/neurological,
growth/size/body,
respiratory system,
mortality/aging, nervous
system
mortality/aging, nervous
system

cytoskeletal protein
binding

establishment of
localization,
signaling

cell projection,
plasma membrane

Transporter

establishment of
localization

plasma membrane

adipose tissue,
behavior/neurological,
skeleton,
growth/size/body

Transporter

cellular
component
organization,
establishment of
localization,
response to
stimulus,
signaling

cell projection,
endoplasmic
reticulum, plasma
membrane, synapse

Kcnq3

Kcnn3

Kcnq2

Kcnq5

Kcnd3

potassium
intermediate/small
conductance calciumactivated channel,
subfamily N, member
3, SK3
potassium voltagegated channel,
subfamily Q, member
2, M-current subunit
potassium voltagegated channel,
subfamily Q, member
5, M-current subunit
potassium voltagegated channel, Shalrelated family,
member 3, Kv4.3

Table 5 | Breakdown of potential candidate potassium genes
The phenotype overview column indicates any direct phenotypes attributed to mutations/alleles of the gene.
Green labels indicate potential candidate genes with novel orexin actions. The cellular component refers to
the location relative to cellular structures in which the channel performs a function. All data was obtained
from Ensembl and mouse genome informatics database.
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Gene
name

Description Phenotype
overview

Molecular
function

Biological
process

Cellular
component

Slc6a4

solute carrier
family 6
(neurotransmitter
transporter,
serotonin),
member 4

cytoskeletal
protein binding,
transporter

solute carrier
family 22
(organic cation
transporter),
member 3, extra
neuronal
monoamine
transporter
solute carrier
family 22
(organic cation
transporter),
member 17, cell
surface receptor
for LCN2 (24p3)
solute carrier
family 22,
member 23
solute carrier
family 25
(mitochondrial
carrier,
glutamate),
member 22

cell differentiation,
cell population
proliferation,
establishment of
localization,
response to stimulus,
signaling, system
development
establishment of
localization,
response to stimulus

cell projection,
cytoplasmic
vesicle,
endosome,
plasma
membrane,
synapse

Slc22a3

behavior/neurological,
cardiovascular, cellular,
digestive/alimentary,
endocrine/exocrine glands,
growth/size/body,
homeostasis/metabolism,
integument, mortality/aging,
muscle, nervous system
Cellular, hematopoietic
system,
homeostasis/metabolism,
immune system, nervous
system, vision/eye

behavior/neurological,
Limbs/digits/tail,
mortality/aging, skeleton

Signaling receptor
activity,
transporter

establishment of
localization,
homeostatic process

Plasma
membrane,
vacuole

N/A

transporter

establishment of
localization

N/A

N/A

transporter

establishment of
localization

Mitochondrion,
organelle
envelope

Slc22a17

Slc22a23
Slc25a22

transporter

Plasma
membrane

Table 6 | Breakdown of potential solute carrier genes
The phenotype overview column indicates any direct phenotypes attributed to mutations/alleles of the gene.
Green labels indicate potential candidate genes with novel orexin actions. The cellular component refers to
the location relative to cellular structures in which the channel performs a function. All data was obtained
from Ensembl and mouse genome informatics database.
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Gene
name

Description

Phenotype

Molecular Biological
function
process

Cellular
component

Hcn3

hyperpolarizationactivated, cyclic
nucleotide-gated K+ 3

cardiovascular system,
nervous system

establishment of
localization

Slc1a4

solute carrier family 1
(glutamate/neutral amino
acid transporter), member
4. Transporter for alanine,
serine, cysteine, and
threonine. Exhibits Na+
dependance
Makes noisy current.
Structural component of
the gap junctions and the
hemichannels involved in
the ATP release and
nucleotide permeation

growth/size/body,
homeostasis/metabolism

carbohydrate
derivative
binding,
transporter
Transporter

cell projection,
plasma
membrane,
synapse
Cell projection,
cytoskeleton,
non-membranebounded
organelle, plasma
membrane

behavior/neurological,
cellular, hematopoietic
system,
homeostasis/metabolism,
immune system, nervous
system, respiratory
system, vision/eye
Vision/eye

cytoskeletal
protein binding,
signaling
receptor
binding,
transporter

establishment of
localization,
response to
stimulus,
signaling

Cell projection,
endoplasmic
reticulum, plasma
membrane

transporter

Golgi apparatus,
nucleus, plasma
membrane

cardiovascular system,
hearing/vestibular/ear,
muscle, nervous system,
renal/urinary system,
vision/eye

transporter

behavior/neurological,
cardiovascular system,
growth/size/body,
hematopoietic system,
homeostasis/metabolism,
immune system,
mortality/aging, nervous
system, renal/urinary
system, respiratory
system
behavior/neurological,
homeostasis/metabolism,
nervous system

transporter

establishment of
localization,
homeostatic
process
Cell death,
cellular
component
organization,
establishment of
localization,
response to
stimulus,
signaling, system
development
establishment of
localization

cellular
component
organization,
establishment of
localization,
homeostatic
process, signaling

Plasma membrane

Panx1

Trpc7

Asic2

transient receptor potential
cation channel, subfamily
C, member 7. Produces
noisy cation current.
acid-sensing (proton-gated)
ion channel 2

Nalcn

sodium leak channel, nonselective

Slc24a2

solute carrier family 24
(sodium/potassium/calcium
exchanger), member 2

transporter

establishment of
localization

Cell projection,
plasma
membrane,
synapse

Table 7 | Breakdown of Na or Ca dependent Non-Voltage gated ion channels
The phenotype overview column indicates any direct phenotypes attributed to mutations/alleles of the gene.
Green labels indicate potential candidate genes with novel orexin actions. The cellular component refers to
the location relative to cellular structures in which the channel performs a function. All data was obtained
from Ensembl and mouse genome informatics database.
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